A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers

Clinical trial NCT00337376 · TERMINATED

Trial details

NCT number: NCT00337376
Sponsor: Yale University
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Cancers

Start date: 2006-02-01
Primary completion: 2010-07-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.